Oslo-based healthtech startup Noteless has secured €3.5 million in fresh seed funding to accelerate the rollout of its AI-powered clinical documentation platform across Europe. The round was led by Redstone, with continued participation from Futurum Ventures and Farvatn Venture. The investment reflects growing demand for tools that ease paperwork pressures for clinicians who are struggling with administrative overload.
Addressing a Persistent Documentation Challenge
Medical documentation has long consumed hours of a clinician’s workday, creating stress and reducing the time available for patient care. High administrative workloads are linked to burnout, job dissatisfaction, and talent attrition across the healthcare sector. Noteless was created to counter this issue by transforming how doctors document consultations.
The Technology Behind Noteless
The company’s platform uses real-time speech recognition and natural language processing to automatically convert doctor-patient conversations into structured medical notes. This approach helps clinicians produce accurate records while eliminating manual typing during or after appointments. The tool is designed specifically for European workflows, supporting multilingual environments and adherence to local regulatory requirements.
Founding Vision and Early Momentum
Noteless was founded in October 2023 by William Vossgård, Mikkel Slettebø, and Sarankan Sivakanesan with the goal of reducing administrative burden and improving clinician wellbeing. The team recognized that excessive documentation requirements hinder meaningful patient interaction and drain time from professional development. Their solution focuses on restoring balance by giving clinicians back hours each day.
Rapid Adoption Across Europe
Since launching its first product in June 2024, Noteless has grown quickly and now works with around 3,000 clinicians across Norway, Denmark, the United Kingdom, Germany, and the Netherlands. The company reports that its platform is processing more than 100,000 patient consultations each week, reflecting momentum in primary care and specialist practices. Adoption has expanded beyond general practitioners to include physiotherapists, psychologists, and other healthcare professionals.
Strong Uptake in the Nordics
CEO William Vossgård highlighted that more than one in four general practitioners in Norway and one in seven in Denmark currently use the service. Clinicians have shared that the platform returns up to two hours per day, which they can redirect toward patient care or personal wellbeing. This feedback reinforces the growing demand for automated tools that streamline documentation workflows.
Scaling Through Fresh Capital
The newly raised seed funding will support the company’s expansion into additional European countries as healthcare providers increasingly seek solutions to reduce administrative pressure. The investment will also enable further development of Noteless’s technology and integration capabilities within regional healthcare systems. Redstone’s Investment Director, Lucas Paul, noted that the company’s traction demonstrates strong alignment between market needs and the platform’s capabilities.
Diversity and Organizational Growth
Noteless has grown its team to 39 employees representing seven countries, with most staff based in Norway. The team spans a wide age range and a mix of professional backgrounds, contributing to a culture shaped by varied experiences and perspectives. The company aims to maintain an inclusive environment as it continues building its European presence.
Building Toward a Broader Clinical Ecosystem
While the company is currently focused on documentation, Vossgård explained that Noteless intends to develop a broader ecosystem of tools for clinicians. The long-term vision involves supporting more aspects of daily clinical work with AI-driven solutions built for Europe’s healthcare environment. The latest investment marks a step toward realizing that roadmap as the platform scales to new users and new markets.
Noteless is positioning itself as a key player in Europe’s shift toward automated clinical documentation, responding to rising administrative pressure in healthcare. Its rapid adoption and expanding geographic footprint demonstrate strong market appetite for AI tools that save time and support clinician wellbeing. With new funding in place, the company is preparing for its next phase of growth across the continent.